Investigational Drug Information for Vilaprisan
✉ Email this page to a colleague
What is the drug development status for Vilaprisan?
Vilaprisan is an investigational drug.
There have been 15 clinical trials for Vilaprisan.
The most recent clinical trial was a Phase 3 trial, which was initiated on June 30th 2017.
The most common disease conditions in clinical trials are Leiomyoma, Myofibroma, and Endometriosis. The leading clinical trial sponsors are Bayer and [disabled in preview].
There are six US patents protecting this investigational drug and one hundred and seventy-four international patents.
Summary for Vilaprisan
| US Patents | 6 |
| International Patents | 174 |
| US Patent Applications | 21 |
| WIPO Patent Applications | 18 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 3 (2017-06-30) |
| Vendors | 14 |
Recent Clinical Trials for Vilaprisan
| Title | Sponsor | Phase |
|---|---|---|
| Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids | Bayer | Phase 3 |
| Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis | Bayer | Phase 2 |
| A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding | Bayer | Phase 3 |
Clinical Trial Summary for Vilaprisan
Top disease conditions for Vilaprisan
Top clinical trial sponsors for Vilaprisan
US Patents for Vilaprisan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Vilaprisan | ⤷ Try a Trial | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Try a Trial |
| Vilaprisan | ⤷ Try a Trial | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE) | ⤷ Try a Trial |
| Vilaprisan | ⤷ Try a Trial | Selective progesterone receptor modulator (SPRM) regimen | BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE) | ⤷ Try a Trial |
| Vilaprisan | ⤷ Try a Trial | Methods of treating uterine fibroids | Myovant Sciences GmbH (Basel, CH) Takeda Pharmaceutical Company Limited (Osaka, JP) | ⤷ Try a Trial |
| Vilaprisan | ⤷ Try a Trial | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | Bayer Pharma Aktiengesellschaft (Berlin, DE) | ⤷ Try a Trial |
| Vilaprisan | ⤷ Try a Trial | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Vilaprisan
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Vilaprisan | Australia | AU2017261372 | 2036-05-05 | ⤷ Try a Trial |
| Vilaprisan | Canada | CA3023278 | 2036-05-05 | ⤷ Try a Trial |
| Vilaprisan | China | CN107847398 | 2036-05-05 | ⤷ Try a Trial |
| Vilaprisan | European Patent Office | EP3452003 | 2036-05-05 | ⤷ Try a Trial |
| Vilaprisan | European Patent Office | EP3981392 | 2036-05-05 | ⤷ Try a Trial |
| Vilaprisan | Hong Kong | HK1249728 | 2036-05-05 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
